Postmenopausal Women

About one in four postmenopausal women have osteoporosis and fractures from osteoporosis cause significant morbidity and mortality. Ongoing treatment trials among women at risk for osteoporosis are critical to decrease the sickness and death associated with this condition. One factor that has limited progress in the area of osteoporosis clinical research is the difficulty recruiting postmenopausal women for participation in clinical trials. Generally speaking, there are few studies that have investigated reasons for non-participation in Randomized Controlled Trials (RCTs) among patient populations and an even fewer number that have examined barriers to recruitment among women in particular; women may have different attitudes towards participation in RCTs than men. As well, most studies that report on barriers to recruitment are based on the researchers’ perspectives rather than the subjects’ opinions. Our study focuses specifically on self-reported barriers to and motivations for participation in an osteoporosis prevention trial (The Nitrates and Bone Turnover Study; NABT) among postmenopausal women, aims to address current knowledge gaps. (Panjwani DD, Hamilton CJ, Reid LS, Jamal SA (2013) Recruiting Postmenopausal Women into Randomized Controlled Trials: A Patient Perspective.)

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on November, 2024